Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole carboxamides as raf kinase inhibitors

Benzimidazole carboxamides as raf kinase inhibitors

US Patent 7691870 · Granted Apr 6, 2010

Estimated economic value: $50,617,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for t2025
Thiophene derivatives2023
Bicyclic heterocyclic derivatives2022
Combination of a protein kinase inhibitor and an additional chemotherapeutic age2022
Arylquinazolines2021
Piperidinyl-propanone derivatives2021
Bicyclic heterocyclic derivatives2020
1,4-dicarbonyl-piperidyl derivatives2020
Bicyclic heterocyclic derivatives2020
Method of treating disorders using a pharmaceutical composition of oligopeptides2019
Piperidinyl derivatives2019
Arylquinazolines2019